Mineralocorticoid Deficiency and Treatment in Congenital Adrenal Hyperplasia

Approximately 75%–80% of patients with Congenital Adrenal Hyperplasia (CAH) fail to synthesize sufficient mineralocorticoids to maintain salt and water balance. In most instances genotype can predict mineralocorticoid deficiency in CAH. Early recognition and replacement with 9α-fludrocortisone and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Padidela, Raja, Hindmarsh, Peter C.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864445/
https://www.ncbi.nlm.nih.gov/pubmed/20454572
http://dx.doi.org/10.1155/2010/656925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864445/
https://www.ncbi.nlm.nih.gov/pubmed/20454572
http://dx.doi.org/10.1155/2010/656925

Ejemplares similares